Efficacy of leptin therapy in the different forms of human lipodystrophy

[1]  K. Clément,et al.  Leptin therapy for partial lipodystrophy linked to a PPAR‐γ mutation , 2008, Clinical endocrinology.

[2]  G. Sebag,et al.  Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy , 2007, Pediatrics.

[3]  P. Gorden,et al.  Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. , 2007, Metabolism: clinical and experimental.

[4]  T. Kusakabe,et al.  Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. , 2007, The Journal of clinical endocrinology and metabolism.

[5]  R. Ahima,et al.  Brain Adipocytokine Action and Metabolic Regulation , 2006, Diabetes.

[6]  J. Yiannias,et al.  Peripheral T‐cell lymphoma presenting as lipoatrophy and nodules , 2006, International journal of dermatology.

[7]  P. Gorden,et al.  Spectrum of renal diseases associated with extreme forms of insulin resistance. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[8]  S. Holland,et al.  Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  R. Ceddia,et al.  Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis , 2005, International Journal of Obesity.

[10]  P. Gorden,et al.  Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. , 2005, Diabetes.

[11]  D. Kleiner,et al.  Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy , 2005, Hepatology.

[12]  P. Gorden,et al.  The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. , 2005, Metabolism: clinical and experimental.

[13]  A. Volpe,et al.  Recombinant human leptin in women with hypothalamic amenorrhea. , 2004, The New England journal of medicine.

[14]  J. Friedman,et al.  Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). , 2004, The Journal of nutrition.

[15]  J. Yanovski,et al.  Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  S. O’Rahilly,et al.  Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[17]  P. Gorden,et al.  Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. , 2004, Metabolism: clinical and experimental.

[18]  P. Gorden,et al.  Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  S. Tóth,et al.  Leptin‐induced signal transduction pathways , 2004, Cell biology international.

[20]  N. Socci,et al.  Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. , 2004, The Journal of clinical investigation.

[21]  Graham M Lord,et al.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.

[22]  P. Gorden,et al.  Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. , 2002, The Journal of clinical endocrinology and metabolism.

[23]  K. Petersen,et al.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.

[24]  M. Reitman,et al.  Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.

[25]  M. Reitman,et al.  Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. , 2001, Diabetes.

[26]  G. Shulman,et al.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.

[27]  K. Fujioka,et al.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. , 1999, JAMA.

[28]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[29]  R. Hammer,et al.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy , 1999, Nature.

[30]  D. Kleiner,et al.  Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. , 2008, The Journal of clinical endocrinology and metabolism.

[31]  Cl ´ õnica.  Intracellular signalling pathways activated by leptin , 2006 .

[32]  B. Kahn,et al.  Leptin signaling in the central nervous system and the periphery. , 2004, Recent progress in hormone research.

[33]  A. Garg,et al.  Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. , 2003, Diabetes care.